ULURU Inc. (ULUR: OTCQB) | ULURU Inc. Reports First Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ULURU Inc. (ULUR: OTCQB) | ULURU Inc. Reports First Quarter 2014 Financial Results ULURU Inc. Reports First Quarter 2014 Financial Results

ULURU Inc. Reports First Quarter 2014 Financial Results

PR Newswire

ADDISON, Texas , May 16, 2014 /PRNewswire/ --  ULURU Inc. (OTCQB: ULUR) today announced its financial results for the first quarter ended March 31, 2014 and provided a review of its operating activities.

Based on the first quarter activities, the Company is confirming the previously communicated outlook for 2014:

  • In February 2014 , we executed agreements to expand the marketing of Altrazeal® to now include Asia and the Pacific (excluding China , Hong Kong , Macau , Taiwan , South Korea , Japan , Australia , and New Zealand ), Jordan , Syria , Albania , Bosnia , Croatia , Kosovo , Macedonia , Montenegro , and Serbia; and
  • Positioning Altrazeal ® to be marketed in approximately 50 markets by the end of 2015.

Commenting on the business activities, Kerry P. Gray , President and CEO, stated, "Great progress has been made expanding our international network of marketing and distribution partners. Currently, there are significant product launch activities taking place in Europe which coincide with the European Wound Management Association meeting being held in Madrid, Spain . We believe that we remain on target to achieve both our primary commercial objectives; to be marketed in over 50 countries by year end and to have substantially expanded our global network of marketing and distribution partners. In addition to our commercial achievements, we have completed the restructuring and simplification of our capital structure and raised $1.8 million through the exercise of a common stock warrant at an exercise price to $0.60 per share. The Company is now in its strongest financial position in years and with a growing revenue stream is well positioned for the future".

For the first quarter of 2014, the Company reported a net loss of $691,000 , or $0.03 per share, compared with a net loss of $657,000 , or $0.06 per share, for the same period last year.

Commenting on the financial results, Kerry P. Gray , President and CEO, stated,
"We are currently working to fill outstanding back orders for Altrazeal for our European distribution partners. Within the next 45 days, we intend to make shipments to over ten markets, but this delay unfavourably impacted our revenues in the first quarter of 2014. With the exception of the investor relation expense and the increase in legal fees associated with a licensing dispute, our expenses remain in line with our projections".

Operating Results

Revenues
Revenues for the first quarter of 2014 were $102,000 , equivalent to the first quarter of 2013. 

Cost of Goods Sold
Cost of goods sold for the first quarter of 2014 was $41,000 , equivalent to the first quarter of 2013.

Research and Development
Research and development expenses for the first quarter of 2014 were $187,000 , including $5,000 in share-based compensation, as compared to $165,000 , which included $1,000 in share-based compensation, for the first quarter of 2013.  The increase of $22,000 in research and development expenses was primarily due to an increase of $29,000 in scientific compensation related to a higher head count and an increase of $20,000 in clinical costs related to Altrazeal®.  These expense increases were partially offset by a decrease of $18,000 in regulatory costs.

Selling, General and Administrative
Selling, general and administrative expenses for the first quarter of 2014 were $469,000 , including $19,000 in share-based compensation, as compared to $261,000 , which included $9,000 in share-based compensation, for the first quarter of 2013.

The increase of approximately $208,000 in selling, general and administrative expenses was primarily due to an increase of $130,000 in investor relations expenses, $81,000 in investor relations consulting, and 2013 being impacted by a $49,000 credit for the cancellation of a warrant issued for consulting services, an increase of $39,000 in legal costs related to a licensing agreement dispute, and an increase of $20,000 in sales and marketing expenses.  These expense increases were partially offset by, a decrease of $12,000 in compensation and a decrease of $11,000 in consulting costs related to licensing activities.

Other income and Other expenses
Interest and miscellaneous income for the first quarter of 2014 was $5,000 as compared to $22,000 for the first quarter of 2013.  The decrease of approximately $17,000 is attributable to a decrease in interest income resulting from the deduction and offset in January 2014 of the outstanding notes receivable against the outstanding principle due on the convertible promissory note with Inter-Mountain.

Interest expense for the first quarter of 2014 was $65,000 as compared to $132,000 for the first quarter of 2013.  The decrease of approximately $67,000 is primarily attributable to the deduction and offset in January 2014 of the outstanding notes receivable against the outstanding principle due on the convertible promissory note with Inter-Mountain and the final payoff in March 2014 of the convertible promissory note with Inter-Mountain.

About ULURU Inc.:
ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex ® Aggregate technology and OraDisc™ transmucosal delivery system. For further information about ULURU Inc., please visit our website at www.uluruinc.com .  For further information about Altrazeal ® , please visit our website at www.altrazeal.com .

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to future financial performance of ULURU Inc. (the "Company"), the anticipated launch of Altrazeal ® in various markets and countries, the achievement of our commercial objectives, our financial position and revenue growth, and the timing of our product shipments.  When used in this press release, the words "believe," "expect" and "anticipate" and similar expressions may be indicative of forward-looking statements including without limitation statements relating to the regulatory results for our products.  These statements by their nature involve substantial risks and uncertainties, certain of which are beyond the Company's control. Any forward-looking statement speaks only as of the date on which such statement is made, and the Company undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of an unanticipated event. Further, management cannot assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.   These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and other reports filed by us with the Securities and Exchange Commission.

Contact: Company
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145

 


ULURU Inc.

SUMMARY OF RESULTS



STATEMENTS OF OPERATIONS DATA




Three Months Ended March 31,


2014


2013

Revenues





License fees

$    14,539


$    11,153


Product sales, net

87,441


90,891


Total Revenues

101,980


102,044





Costs and Expenses





Cost of goods sold

41,042


40,889


Research and development

187,595


165,285


Selling, general and administrative

469,073


260,690


Amortization of intangible assets

117,161


117,161


Depreciation

60,554


65,388


Total Costs and Expenses

875,425


649,413

Operating (Loss)

(773,445)


(547,369)





Other Income (Expense)





Interest and miscellaneous income

4,541


22,465


Interest expense

(65,259)


(131,686)


Equity in earnings (loss) of unconsolidated subsidiary

---


---


Gain on early extinguishment of convertible note

142,703


---

(Loss) Before Income Taxes

(691,460)


(656,590)






Income taxes

---


---

Net (Loss)

$(691,460)


$(656,590)






Less preferred stock dividends

---


(12,021)

Net (Loss) Allocable to Common Stockholders

$(691,460)


$(668,611)









Basic and diluted net (loss) per common share

$  (0.03)


$  (0.06)





Weighted average number of common shares outstanding

21,416,265


11,657,123





 

ULURU Inc.


SELECTED CONDENSED CONSOLIDATED BALANCE SHEET DATA






March 31, 2014


December 31, 2013


(Unaudited)


(Audited)





  Cash and cash equivalents

$         1,015,778


$             5,119

  Current assets

1,781,151


1,487,324

  Property and equipment, net

594,055


638,614

  Other assets

3,571,745


3,775,676

  Total assets

5,946,951


5,901,614





  Current liabilities

2,013,271


3,270,064

  Long term liabilities – convertible notes payable

---


---

  Long term liabilities – deferred revenue

883,594


898,133

  Total liabilities

2,896,865


4,168,197

  Total stockholders' equity

3,050,086


1,733,417

 

SOURCE ULURU Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 150

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Home Energy Tips: Embrace the Electrical Panel Shift

Updated Category News Views 75

Why Electrical Panels Matter More Than Ever Back in the day, electrical panels weren't exactly the star of the homeowner show. But times have changed, and those previously mundane boxes of switches and wires now demand a spotlight. Shifts in modern lifestyles have catapulted electrical systems into the spotlight, making upgrades a pressing conversation topic for savvy...

Continue Reading
Rakuten Medical Fires Up Phase 1 Trial for RM-0256 Therapy

Updated Category News Views 203

Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 113

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Austin Rattler Event Revamps With Two-Day Off-Road Bash

Updated Category News Views 25

Austin's Off-Road Bash Kicks Up Dust in Hill Country It's not just another grind in the biking and running world; the Life Time Austin Rattler's gone off the reservation pushing the pedals and the pace across the rugged terrain of Texas Hill Country. Here's to muscles burning and soles slapping the dirt for two straight days, all in the name of challenging nature's best....

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 97

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 158

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Surgical Tooth Extraction: When It’s Necessary

Updated Category News Views 144

Unpacking the Complexities of Tooth Extraction Ever wonder why some tooth extractions are a stroll in the park while others dive straight into surgical territory? It's all about positioning, condition, and what's lurking underneath. Thanks to Dr. Yadira Cardona-Rohena of Hamilton Mill Oral & Facial Surgery, we’ve got the lowdown. The Need for Skilled Surgical Techniques...

Continue Reading
NEDHSA Amplifies Tobacco-Free Push with 2026 Smokeout

Updated Category News Views 73

2026 Great American Smokeout: A Fresh Push Against Tobacco NEDHSA is sticking to its guns with a tobacco-free campaign that’s got deep roots. The 2026 Great American Smokeout, on November 19, not only highlights past efforts but looks to stir more folks into healthier habits. Beyond the campaign glitz, it’s about dragging a century-long bad habit further into the...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 85

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Daily NAVs of WisdomTree ETFs

Updated Category News Views 110

Daily Net Asset Values of WisdomTree ETFs In the dynamic world of exchange-traded funds (ETFs), keeping track of daily Net Asset Values (NAVs) is crucial for investors looking to understand fund performance. WisdomTree Issuer plc has been a significant player in the ETF arena, offering various products that cater to diverse investment strategies. Each ETF represents a...

Continue Reading
How E-commerce Optimization Services Can Improve SEO Rankings

Updated Category Business Views 736

In the digital world, e-commerce companies flourish by being seen and recognized online. As competition grows fiercer, it becomes essential for e-commerce companies to distinguish themselves from competitors. E-commerce optimization services can boost rankings on search engines. Learning how to use e-commerce optimization strategies can help your business achieve business...

Continue Reading
Upcoming Financial Results Announcement by United Maritime

Updated Category News Views 191

Upcoming Financial Results Announcement by United Maritime GLYFADA, Greece — United Maritime Corporation (NASDAQ: USEA) is set to unveil its financial results for the first quarter ending on March 31. The announcement will be made before the market opens in New York on Thursday. Company Overview United Maritime Corporation is recognized as an international shipping...

Continue Reading
Texas Takes Legal Action Against Biden Over Lizard Protection

Updated Category News Views 91

Texas Attorney General Takes on Endangered Species Status In a noteworthy legal move, Texas Attorney General Ken Paxton has launched a lawsuit against the Biden administration over the recent endangered classification of the dunes sagebrush lizard. This designation, made by the U.S. Fish and Wildlife Service, has drawn significant criticism from Paxton, who contends that...

Continue Reading
Kevin T. Carter Takes the Helm as TCMA's Executive VP

Updated Category News Views 215

TCMA Welcomes a New Leader Trade Center Management Associates, LLC (TCMA, A Drew Company), has recently elevated Kevin T. Carter to the position of Executive Vice President. With a remarkable 45 years in the hospitality industry, Carter's extensive knowledge will guide the company’s strategic initiatives, ensuring robust operational leadership and exciting business...

Continue Reading